Optimization of preparation technology and <italic style="font-style: italic">in vitro </italic>release of baicalin-glycyrrhizic acid solid nanocrystals

XIE Long; ZHAO Yuxin; LIU Kai; GU Huan; LI Xiaofang

doi:10.6039/j.issn.1001-0408.2023.23.03

您当前的位置：

首页 >

文章列表页 >

Optimization of preparation technology and in vitro release of baicalin-glycyrrhizic acid solid nanocrystals

更新时间：2023-12-08

- Optimization of preparation technology and in vitro release of baicalin-glycyrrhizic acid solid nanocrystals
- ZHONGGUO YAOFANG Vol. 34, Issue 23, Pages: 2829-2834(2023)
- 作者机构：
  
  1.成都中医药大学西南特色中药资源国家重点实验室，成都　611137
  2.成都中医药大学药学院，成都　611137
- 作者简介：
- 基金信息：
- DOI：10.6039/j.issn.1001-0408.2023.23.03
  CLC： R943
- Published：15 December 2023，
  
  Received：25 August 2023，
  
  Revised：09 October 2023，
扫描看全文
谢龙,赵雨芯,刘凯等.黄芩苷-甘草酸纳米晶的制备工艺优化及体外释放考察 ^Δ[J].中国药房,2023,34(23):2829-2834.

XIE Long,ZHAO Yuxin,LIU Kai,et al.Optimization of preparation technology and in vitro release of baicalin-glycyrrhizic acid solid nanocrystals[J].ZHONGGUO YAOFANG,2023,34(23):2829-2834.
谢龙,赵雨芯,刘凯等.黄芩苷-甘草酸纳米晶的制备工艺优化及体外释放考察 ^Δ[J].中国药房,2023,34(23):2829-2834. DOI： 10.6039/j.issn.1001-0408.2023.23.03.

XIE Long,ZHAO Yuxin,LIU Kai,et al.Optimization of preparation technology and in vitro release of baicalin-glycyrrhizic acid solid nanocrystals[J].ZHONGGUO YAOFANG,2023,34(23):2829-2834. DOI： 10.6039/j.issn.1001-0408.2023.23.03.

摘要

目的

优化黄芩苷（BCN）-甘草酸（GA）纳米晶（BCN-GA-SN）的制备工艺，并进行表征和体外释放考察。

方法

根据经典药对“黄芩-甘草”配伍比例，固定BCN和GA的配伍比例为6∶1（

），采用沉淀法结合高压均质法制备BCN-GA纳米混悬液。以平均粒径、多分散性指数（PDI）为评价指标，以稳定剂的种类及用量、搅拌转速和时间、高压均质压力和次数为考察因素，优化BCN-GA纳米混悬液制备工艺；再以平均粒径、PDI、再分散系数（RDI）为评价指标，以冻干保护剂种类和用量为考察因素，优化BCN-GA纳米混悬液的冻干固化工艺，进而制备BCN-GA-SN；然后对BCN-GA-SN的理化性质表征和体外释放进行考察。

结果

BCN-GA-SN的最优制备工艺为：先以15%十二烷基硫酸钠为稳定剂，1 000 r/min搅拌15 min，100 MPa高压均质20次制备BCN-GA纳米混悬液；再以5%甘露醇（相对于BCN的用量）冻干固化。所制得的BCN-GA-SN的平均粒径为（442.2±5.7） nm，PDI为0.225±0.015，RDI为1.055±0.013，呈不规则球形，大小较为均匀；该纳米晶中BCN的载药量为（62.5±0.7）%，GA的载药量为（9.4±0.2）%；体外释放结果表明，BCN-GA-SN的累积溶出度均高于BCN、GA的物理混合物。

结论

本研究成功制备了BCN-GA-SN，其粒径大小均一、分布均匀，可有效提高BCN的体外溶出度。

Abstract

OBJECTIVE

To optimize the preparation technology of baicalin （BCN）-glycyrrhizic acid （GA） solid nanocrystals （BCN-GA-SN）， to characterize them and investigate their

in vitro

release characteristics.

METHODS

According to the compatibility ratio of classic couplet medicinals “

Scutellaria baicalensis

Glycyrrhiza uralensis

”， the compatibility ratio of BCN and GA was determined as 6∶1 （

）； BCN-GA nanosuspension was prepared by precipitation method combined with high-pressure homogenization method. The preparation technology of BCN-GA nanosuspension was optimized by using mean particle size and polydispersity index （PDI） as indexes and with types and dosage of stabilizers， stirring speed and time， high-pressure homogenization pressure and frequency as factors. The freeze-dried consolidation process of BCN-GA nanosuspension was optimized to prepare BCN-GA-SN using average particle size， PDI and redispersibility index （RDI） as indicators， with the type and dosage of freeze-dried protective agents as factors； then， the physicochemical properties and

in vitro

release of BCN-GA-SN were investigated.

RESULTS

The optimal preparation technology of BCN-GA-SN was as follows： BCN-GA nanosuspension was prepared by using 15% sodium dodecyl sulfate as a stabilizer， stirring at 1 000 r/min for 15 minutes， and homogenizing at 100 MPa for 20 times； then， BCN-GA nanosuspension was freeze-dried and solidified with 5% mannitol （corresponding to the dosage of BCN）. The average particle size of prepared BCN-GA-SN was （442.2±5.7） nm with PDI of 0.225±0.015 and RDI of 1.055±0.013. The prepared BCN-GA-SN presented as the irregularly spherical shape with more uniform size； the drug-loading amount of BCN in the nanocrystal was （62.5±0.7）%， and that of GA was （9.4±0.2）%； the

in vitro

release results showed that the cumulative dissolution of BCN-GA-SN was higher than that of the physical mixture of BCN and GA.

CONCLUSIONS

BCN-GA-SN is prepared successfully in this study with uniform particle size and even distribution， which can effectively improve the dissolution of BCN.

关键词

黄芩-甘草药对黄芩苷甘草酸纳米晶体外释放

Keywords

baicalinglycyrrhizic acidnanocrystalsin vitro release

references

ZHAO T T，TANG H L，XIE L，et al. Scutellaria baicalensis Georgi. （Lamiaceae）：a review of its traditional uses，botany，phytochemistry，pharmacology and toxicology[J]. J Pharm Pharmacol，2019，71（9）：1353-1369.

SHEN C Y，SHEN B D，ZHU J J，et al. Glycyrrhizic acid-based self-assembled micelles for improving oral bioavaila- bility of paeoniflorin[J]. Drug Dev Ind Pharm，2021，47（2）：207-214.

吕志阳，单聪，杨雨微，等. 经方中黄芩-甘草不同配伍比例对黄芩苷溶出的影响[J]. 亚太传统医药，2019，15（10）：67-69.

LYU Z Y，SHAN C，YANG Y W，et al. Effect of baicalin in licorice by different compatibility proportions of Scutellariae Radix and Glycyrrhizae Radix[J]. Asia Pac Tradit Med，2019，15（10）：67-69.

刘柳毅，温璐平，许男徽，等. 灯盏花素纳米晶的制备及质量评价[J]. 中国药房，2020，31（15）：1861-1867.

LIU L Y，WEN L P，XU N H，et al. Preparation and quality evaluation of breviscapine nanocrystals[J]. China Pharm，2020，31（15）：1861-1867.

NAGARWAL R C，KUMAR R，DHANAWAT M，et al. Nanocrystal technology in the delivery of poorly soluble drugs：an overview[J]. Curr Drug Deliv，2011，8（4）：398-406.

刘罗娜，李小芳，仲粒，等. 以甘草酸为稳定剂制备黄芩苷固体纳米晶体[J]. 中草药，2019，50（9）：2057-2064.

LIU L N，LI X F，ZHONG L，et al. Preparation of baicalin solid nanocrystal using glycyrrhizic acid as a natural stabilizer[J]. Chin Tradit Herb Drugs，2019，50（9）：2057-2064.

国家药典委员会. 中华人民共和国药典：一部[M]. 2020年版.北京：中国医药科技出版社，2020：88-89，314-316.

Chinese Pharmacopoeia Commission. Chinese pharmacopoeia：volume Ⅰ[M]. 2020 edition. Beijing：China Medical Science and Technology Press，2020：88-89，314-316.

樊俐慧，张伟，孙静，等. 《伤寒杂病论》中黄芩的量效关系及用药规律[J]. 中成药，2021，43（4）：1015-1017.

FAN L H，ZHANG W，SUN J，et al. Dose-effect relationship and medication law of Scutellaria baicalensis Georgi in Treatise on Febrile Diseases[J]. Chin Tradit Pat Med，2021，43（4）：1015-1017.

刘楚妤，赵琰，屈会化. 经方中黄芩应用规律探讨[J]. 辽宁中医药大学学报，2021，23（12）：139-143.

LIU C Y，ZHAO Y，QU H H. Discussion on the application rules of Scutellariae Radix in the classical prescriptions[J]. J Liaoning Univ Tradit Chin Med，2021，23（12）：139-143.

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

碱性成纤维生长因子纳米粒的制备及体外释放研究

多层海藻酸-壳聚糖聚电解质膜微球的制备与体外释放特性研究

叶酸修饰pH敏感聚酰胺-胺多柔比星复合物的合成及表征

聚乙二醇对盐酸伊立替康脂质体体外释放及在不同稀释介质中稳定性的影响

PLGA-PEG多孔载药微球的制备及超声波对其释药行为的影响研究

Related Author

刘慧娜王玮

南艳微郑晓玲

胡青季鹏黄发珍朱亚勤程亮程丽芳陈大为

李哲马海英

袁晓明

吕珊?许瑞祥?蒋岑岑?陈勇川?岑菁?

张宏梅崔佰吉郭淑英

YUAN Hailong

Related Institution

No data

Address：8/F,129 Daping Main Street,Yuzhong District,Chongqing 400042,P.R.China
Technical support is provided by Beijing Founder Electronics co., LTD 渝ICP备15012710号公网安备50010302001817
It is recommended to read the content of this site in Chrome&IE9+. Please switch to extreme mode in browser 360.
Cookies We use cookies to help provide and enhance our service and tailor content. By continuing, you agree to the use of cookies.

⁰

Optimization of preparation technology and in vitro release of baicalin-glycyrrhizic acid solid nanocrystals

DOI：10.6039/j.issn.1001-0408.2023.23.03

摘要

Abstract

关键词

Keywords

references